Study: Psychedelics Disrupt Brain-Immune Signals That Promote Fear
Fear and the immune system could be connected in unexpected ways. Researchers at Mass General Brigham, in affiliation with Harvard Medical School, found that the immune system influences stress and fear behaviors by altering how brain cells communicate. Using preclinical models and human tissue samples, they also found that psychedelics could target these neuroimmune interactions, disrupting them to reduce stress-induced fear. The findings were published April 23 in Nature.
The amygdala, known as the brain's fear center, processes threats. Some fears—like the fight-or-flight response—are essential for survival. Others pile up and become overwhelming. Researchers believe psychedelics such as MDMA and psilocybin may interrupt unhelpful neuroimmune signals when anxiety, depression, and conditions occur.
Michael Wheeler, a founding member of the Mass General Brigham health care system, is based at the Gene Lay Institute of Immunology and Inflammation and the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital in Boston.
'Our research shows that psychedelics don't just have powerful effects on the brain's ability to adapt and change, they also seem to rebalance the way the brain interacts with the body,' Wheeler said in an exclusive statement. 'We found that by limiting the brain's exposure to fear-promoting signals from nearby immune cells, psychedelics might help keep the immune system in check, offering unexpected benefits beyond cognitive effects.'
The study provides insight into the mechanisms at play when psychedelics interact with both the brain and the body, shedding light on their expanding potential in therapeutic settings.
Research in the past has shown immune signals can promote the development of neuropsychiatric conditions such as major depressive disorder (MDD). Looking ahead, psychedelics may provide useful tools in controlling these signals.
In experiments with mouse models under chronic stress, researchers observed increased signaling in the amygdala that amplified fear behaviors, triggered inflammatory responses, and activated fear-promoting neurons. They also found that during chronic stress, inflammatory immune cells called monocytes migrated from other parts of the body to the brain. When stressed mice were given psilocybin and MDMA, monocyte accumulation in the brain was reduced, and fear behaviors decreased.
'We're especially excited to keep exploring how the immune system factors into psychedelic therapy, both in humans and in mice, and to see whether psychedelics could also have potential as treatments for other inflammatory diseases,' Wheeler wrote.
They also found similar signals in human brain cells and in gene expression datasets from patients with MDD, suggesting that the same interactions between the immune system and the brain may pave the way for treatments for neuropsychiatric disorders.
Wheeler is also collaborating with Massachusetts General Hospital Center for the Neuroscience of Psychedelics on a clinical trial of people with depression who are being treated with psychedelic, examining their tissue samples.
Wheeler and colleagues expressed interest in further examining the effects of psychedelics on people with depression and inflammatory diseases. Mass General Brigham, one of the nation's leading biomedical research organizations, operates across several Harvard Medical School hospitals.
Recent strides have been made in demonstrating the therapeutic effects of psychedelics like MDMA. The FDA initially acknowledged MDMA's therapeutic potential for PTSD, but ultimately rejected a new drug application, submitted by Lykos Therapeutics (formerly MAPS Public Benefit Corporation). Amid the psychedelic renaissance in medicine, research is leading to potential benefits from psilocybin for treatment-resistant depression, MDD, and addiction.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNET
4 hours ago
- CNET
This Nature App Uses AI to Turn Anyone Into a Wildlife Expert. Here's How to Get Started
When I recently moved, one of the building's standout features was the plethora of different plant species in front of its windows. But not like standard landscaping -- more like drier plants, seemingly native to the area. Curious and fairly incompetent in plant sciences, I looked for help in being able to categorize and understand more about it. That's how I found Seek by iNaturalist, a free app where you take photos of plants, animals and fungi. Artificial intelligence suggests its type -- with human confirmation -- while your input and contributions elevate scientific research. What is Seek and how does it use AI? Founded in 2008 as a master's project from UC Berkeley students, iNaturalist later became a joint initiative between the California Academy of Sciences and the National Geographic Society. It strives to connect people to nature and conservation through crowdsourced data. Today, it contains more than 250 million observations of more than a half-million species. (And I just added seven more in roughly 5 minutes.) Seek by iNaturalist is 100% free thanks to donors who contributed to the platform. It operates as a nonprofit organization that makes all collected data -- with the option to turn it off -- openly accessible to scientists and conservationists worldwide. iNaturalist uses computer vision AI to analyze uploaded photos against a model trained on millions of previous observations. AI is also used on the back end -- it optimizes species recognition accuracy, to display the most relevant photos alongside suggestions and pattern recognition improvements. This helps you distinguish between similar-looking species at home or across your local ecosystems. According to the iNaturalist team, "When you use the AI camera feature on any wild living thing, iNaturalist suggests an identification for what you might be seeing -- whether plant, insect, fungus or other organism." They shared that from there, that photo becomes a useful piece of data for science and conservation. But ultimately, a community of naturalists confirm or correct those AI suggestions. Together, AI and human intelligence help newcomers contribute to biodiversity documentation from their first upload. How to use iNaturalist to spot and categorize nature 1. First search for Seek in your app store of choice and create an account by signing up with email or a social media authenticator. You'll also need to allow camera and location permissions to be able to use the AI's computer vision and accurately detect species. 2. It's best to play around a bit before starting scans. Open the app and tap the camera button -- it's designed to recognize any plant, animal and fungi. I focused solely on plants, as that's what I had readily available. Snap a couple photos or hold the camera button down to snap continuously. Using iNaturalist's AI camera to identify a plant species. Screenshot by CNET As you're testing the camera out, note background images, angles and even lighting, which all play a part in the AI tool's ability to accurately recognize what you've captured. (I had to redo a couple because an attempt to take a birds-eye shot ended up with pictures of my feet.) 3. Next, the AI computer vision will analyze your photo and suggest possible species. This takes no longer than 30 seconds. Here you can also record GPS coordinates and you have the option to add details about behavior, size and other aspects of whatever it is you observed and captured. Beyond this, you can also toggle between privacy options, and select whether it is captive, like a plant, or wild, like natural growth. 4. AI also has suggestions for your species identification, which show up as percentages for accuracy. You can also post your observation -- if geoprivacy is open -- to the community for review by users and experts, like scientists. Once the community confirms your species, your observation becomes scientific data. The point here is that you are part of the collection process for scientists to learn more about species in the world. With your input and the community's approval, you're directly involved in this process. Think of yourself as a bridge between reality and what scientists are constantly trying to understand and improve. The iNaturalist team provided tips for getting the best results, alongside checking out their company guides, or downloading the Seek user guide: treat AI suggestions as a starting point, and engage with other humans; explore information on iNaturalist's database; and be aware that there are more advanced camera suggestions in the iPhone app over the Android app. Should you use iNaturalist? The app is designed like Instagram for nature lovers, with a volunteer process that positions itself as additional help for scientists' discoveries. In my opinion, technology that helps connect people to nature and advances scientific understanding is inherently valuable for our planet and future generations. Some of the privacy options available on the iNaturalist Seek app when you upload your observations. iNaturalist / Screenshot by CNET But even though Seek operates globally, with 3.7 million users, the identification accuracy depends heavily on having active expert communities in your region. This means rural or less-populated areas might get slower species confirmations. Additionally, the topic of AI ethics comes to mind. I asked the iNaturalist team about this. They responded that the location is important for information when correctly identifying species, especially wild ones. Yet they also noted that anyone using iNaturalist can "choose to obscure the precise locations of observations to protect their privacy" and that you can use the AI identification feature without creating an account or posting publicly. The iNaturalist team also regularly updates the Privacy Policy in support of the well-being of the community. The main goal is to create an open biodiversity dataset that can be used to protect nature around the world. Overall, Seek by iNaturalist is a great way to educate yourself and contribute to multiple versions of ecosystems in the process while learning and sharing your findings along the way -- or, as the iNaturalist team shared, a "virtuous cycle of collective effort and improvement, built on community trust and benefit in service of helping people connect with nature and biodiversity worldwide."
The Hill
2 days ago
- The Hill
Flu, COVID can reawaken dormant breast cancer cells: Study
Respiratory infections like COVID-19 and the flu can activate dormant cancer cells in breast cancer patients who are in remission, new research finds. The study, published in Nature, found that common viruses can reawaken small numbers of dormant breast cancer cells in the lungs. Researchers began investigating the link after the team noticed that U.K. patients who were in remission from breast cancer and tested positive for COVID later showed a two-fold increase in cancer-related deaths. They also analyzed a U.S. database that included nearly 37,000 patients and found that COVID infection was associated with a more than 40 percent increased risk of metastatic breast cancer in the lungs. Studies on mice found that influenza and COVID infections triggered dormant breast cancer cells after just days of infection. Within two weeks, researchers observed 'massive expansion' of the cancer cells into metastatic lesions by more than 100 times. Scientists have suspected that common viruses like Epstein-Barr can trigger some cancers. Human papillomavirus (HPV) is already documented to trigger cervical cancer. When it comes to breast cancer, however, research on human cells was limited, and it's not entirely known how the virus triggers the disease to spread. The findings suggest the body's immune response plays a role. After breast cancer goes into remission, a tiny number of cells remain dormant in lung, bone and liver tissue. Sometimes, inflammation can wake up the cells. In the mouse experiments, both influenza A and coronavirus only reawakened dormant cells if they triggered an inflammatory cytokine response. More research is needed to see if vaccination makes a difference when it comes to the possibility of reawakening dormant cells.
Yahoo
3 days ago
- Yahoo
What is Lyme disease, and does Justin Timberlake have it?
Justin Timberlake isn't the only person to recently contract tick-borne Lyme disease. New Jersey had the third-most cases of Lyme disease in the nation as recently as 2022, according to the New Jersey Department of Health. And with Lyme disease outbreaks on the rise throughout the country, here's what you need to know about Lyme disease and steps you can take to protect yourself and your family. What is Lyme disease? Lyme disease is caused by tick bites but isn't spread person-to-person, noted the the New Jersey Department of Health. The Lyme disease-causing ticks thrive in woodsy areas, such as much of New Jersey. What are Lyme disease symptoms? The three stages of Lyme disease have different symptoms, according to PennMedicine: Stage 1: chills; fevers; joint and muscle pain Stage 2: Nerve numbness; facial paralysis; fainting spells; meningitis Stage 3: fluid buildup in joints; neuropathy How you can prevent, treat Lyme disease The New Jersey Department of Health advises you to avoid wooded areas with dense shrubs and leaf litter, wearing protective clothing, using insect repellents, perform tick checks and mowing lawns frequently will help you avoid tick bites and Lyme disease. "After spending time in tick-infested areas, ask a partner to check you for ticks in areas on your body that you can't see very well," advised the Harvard Medical School. "The common bite areas are the back of the knee, the groin, under the arms, under the breasts in women, behind the ears, and at the back of the neck." Justin Timberlake confirms Lyme disease diagnosis Superstar pop singer Justin Timberlake told his fans in an instagram post that his Lyme disease diagnosis nearly forced him off tour. "Among other things, I've been battling some health issues, and was diagnosed with Lyme disease - which I don't say so you feel bad for me - but to shed some light on what I've been up against behind the scenes," read a portion of Timberlake's lengthy Instagram post. "If you've experienced this disease or know someone who has, then you're aware: living with this can be relentlessly debilitating, both mentally and physically. "When I first got the diagnosis I was shocked for sure. But, at least I could understand why I would be onstage and in a massive amount of nerve pain or, just feeling crazy fatigue or sickness," Timberlake's post continued. "I was faced with a personal decision. Stop touring? Or, keep going and figure it out. I decided the joy that performing brings me far outweighs the fleeting stress my body was feeling. I'm so glad I kept going." According to Business Insider, Timberlake is just the most recent celebrity to come down with Lyme disease. In 2020, both Justin Bieber and Amy Schumer reportedly confirmed their Lyme disease diagnosis, and Avril Lavigne was reportedly bedridden by Lyme disease in 2014. Damon C. Williams is a Philadelphia-based journalist reporting on trending topics across the Mid-Atlantic Region. This article originally appeared on What is Lyme disease, and did Justin Timberlake say he had it? Solve the daily Crossword
